Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, and eicosapentaenoic acid. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

CEO

ISIN

US0231114044

WKN

000A41557

Listings

0 Comments

Share your thoughts

FAQ

What is Amarin stock price today?▼

The current price of EH3.F is €12.2 EUR — it has increased by +1.67% in the past 24 hours. Watch Amarin stock price performance more closely on the chart.

What is Amarin stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange Amarin stocks are traded under the ticker EH3.F.

Is Amarin stock price growing?▼

EH3.F stock has fallen by -0.81% compared to the previous week, the month change is a +1.67% rise, over the last year Amarin has showed a +95.51% increase.

What is Amarin revenue for the last year?▼

Amarin revenue for the last year amounts to 434.39M EUR.

What is Amarin net income for the last year?▼

EH3.F net income for the last year is -156.74M EUR.

When did Amarin complete a stock split?▼

The last stock split for Amarin was on April 11, 2025 with a ratio of 1:20.